Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

AVENUE THERAPEUTICS, INC. (ATXI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-K10-K
Operating expenses:         
Research and development  2.71.32.922.217.76.71.3
General and administrative  5.32.52.33.14.13.61.0
    Loss from operations  -8.0-3.7-5.2-26.3-21.8-11.4-2.4
   
Other income (expense)         
Interest income  0.00.00.10.40.10.1 
Change in fair value of warrant liabilities  -5.6    0.50.2
    Net loss  -3.6-3.7     
Net loss attributable to non-controlling interests  -0.1      
    Net loss attributable to common stockholders  -3.6-3.7-5.2-25.9-21.5-12.3-3.2
   
Net loss per common share attributable to common stockholders, basic and diluted  ($1.63)($3.29)($0.31)($1.65)($2.10)($1.85)($1.11)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy